SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0000874015-23-000099
Filing Date
2023-02-14
Accepted
2023-02-14 16:53:28
Documents
1
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 5  
1 PRIMARY DOCUMENT primary_doc.xml 5 3587
  Complete submission text file 0000874015-23-000099.txt   5053
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Issuer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ASPREVA PHARMACEUTICALS CORPORATION 1203-4464 MARKHAM STREET VICTORIA A1 V8Z 7X8
Business Address
Hayden Michael R (Reporting) CIK: 0001352908 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-19125 | Film No.: 23630967